Results for tag: "Autologous Cultured Chondrocyte"

The Autologous Cultured Chondrocyte market is a subset of the Orthopedic Devices market. It is a type of cell therapy that uses a patient's own cells to repair damaged cartilage in the knee, shoulder, and other joints. The procedure involves harvesting healthy cartilage cells from the patient, culturing them in a laboratory, and then re-implanting them into the damaged area. This procedure has been shown to be effective in restoring joint function and reducing pain. The Autologous Cultured Chondrocyte market is growing due to the increasing prevalence of joint diseases and the need for effective treatments. The market is expected to benefit from the development of new technologies and the increasing availability of cell-based therapies. Some of the major players in the Autologous Cultured Chondrocyte market include Vericel Corporation, CartiHeal, and Osiris Therapeutics. Other companies in the market include Histogenics Corporation, Orthocell, and RegenexBio. Show Less Read more